PAR 5.77% 24.5¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM REPORTS IND APPLICATION UPDATE, page-74

  1. 830 Posts.
    lightbulb Created with Sketch. 207
    just another opportunity presents itself yet again, from the impatient to the patient the profits flow, this is so close now i can smell the wads of cash.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.